Bank Hapoalim BM’s Scinai Immunotherapeutics SCNI Stock Holding History

Bank Hapoalim BM’s Portfolio SCNI Stock Details SCNI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-7	Closed	-$254K	–	203
2020 Q3	$254K	Sell	7 -2	-22%	-$76.8K	0.01%	157
2020 Q2	$207K	Buy	+9	New	+$145K	0.05%	174
2020 Q1	–	Sell	-25	Closed	-$232K	–	184
2019 Q4	$232K	Hold	25	–	–	0.05%	157
2019 Q3	$148K	Hold	25	–	–	0.04%	162
2019 Q2	$144K	Hold	25	–	–	0.04%	169
2019 Q1	$135K	Hold	25	–	–	0.03%	161
2018 Q4	$119K	Hold	25	–	–	0.04%	150
2018 Q3	$141K	Sell	25 -2	-7%	-$11.9K	0.03%	177
2018 Q2	$180K	Hold	27	–	–	0.05%	177
2018 Q1	$146K	Buy	+27	New	+$168K	0.04%	179

Other funds holding SCNI

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $6.54B AUM

Bank Hapoalim BM's SCNI Position: Q4 2020 in Review

Bank Hapoalim BM sold out of Scinai Immunotherapeutics (SCNI) in Q4 2020, closing a stake of 7 shares — an estimated $254K sold.

Bank Hapoalim BM first reported a position in SCNI in Q1 2018 and held it in 10 quarters. The position peaked at $254K in Q3 2020. 10 funds tracked by Wall St. Rank hold SCNI as of Q4 2020.

Bank Hapoalim BM reported no remaining Scinai Immunotherapeutics position as of Q4 2020 after selling out during the quarter.
Bank Hapoalim BM sold 7 Scinai Immunotherapeutics shares in Q4 2020, an estimated $254K.
Bank Hapoalim BM first reported a position in Scinai Immunotherapeutics in Q1 2018 and held it in 10 quarters.
Bank Hapoalim BM's Scinai Immunotherapeutics position peaked at $254K in Q3 2020.
10 funds tracked by Wall St. Rank held Scinai Immunotherapeutics as of Q4 2020.

Based on Bank Hapoalim BM's 13F filing for Q4 2020, filed 3 Feb 2021.